The bioprocessing industry is facing increasing challenges triggered by the high demands on flexibility, productivity, and cost-efficiency. Boehringer Ingelheim BioXcellence™ has converted these challenges into a wide portfolio of upstream and downstream processing technologies.
In addition to traditional and hybrid clinical processing, Boehringer Ingelheim BioXcellence™ offers a full disposable concept. Our customers benefit from the fact that this concept has been implemented globally at our cell culture sites in Biberach (Germany), Fremont (USA), and Shanghai (China).